| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.257 | |
| amine metabolic process | GO:0009308 | 45 | 0.192 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.180 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.179 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.149 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.144 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.136 | |
| cell adhesion | GO:0007155 | 329 | 0.127 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.123 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.123 | |
| urogenital system development | GO:0001655 | 261 | 0.104 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.104 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.101 | |
| kidney development | GO:0001822 | 213 | 0.092 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.088 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.086 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.085 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.084 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.084 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.083 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.083 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.082 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.080 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.080 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.079 | |
| renal system development | GO:0072001 | 225 | 0.077 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.074 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.073 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.072 | |
| rhythmic process | GO:0048511 | 174 | 0.072 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.070 | |
| protein glycosylation | GO:0006486 | 55 | 0.068 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.068 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.067 | |
| regulation of cell activation | GO:0050865 | 289 | 0.067 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.067 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.066 | |
| placenta development | GO:0001890 | 140 | 0.066 | |
| vegf activated neuropilin signaling pathway | GO:0038190 | 2 | 0.063 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.063 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.063 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.062 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.062 | |
| response to growth factor | GO:0070848 | 198 | 0.061 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.060 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.059 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.059 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.059 | |
| kidney epithelium development | GO:0072073 | 121 | 0.059 | |
| glycosylation | GO:0070085 | 62 | 0.059 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.059 | |
| response to radiation | GO:0009314 | 165 | 0.057 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.057 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.057 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.056 | |
| female gonad development | GO:0008585 | 71 | 0.056 | |
| gland development | GO:0048732 | 330 | 0.056 | |
| response to x ray | GO:0010165 | 11 | 0.055 | |
| oxidation reduction process | GO:0055114 | 342 | 0.055 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.054 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.054 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.054 | |
| nephron development | GO:0072006 | 109 | 0.054 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.054 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.054 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.054 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.054 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.053 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.053 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.053 | |
| blood circulation | GO:0008015 | 195 | 0.053 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.053 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.052 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.052 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.051 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.051 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.051 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.051 | |
| circulatory system process | GO:0003013 | 197 | 0.050 | |
| regulation of system process | GO:0044057 | 200 | 0.050 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.050 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.050 | |
| lung development | GO:0030324 | 164 | 0.050 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.050 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.050 | |
| muscle system process | GO:0003012 | 141 | 0.049 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.049 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.049 | |
| cytokine production | GO:0001816 | 319 | 0.049 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.048 | |
| connective tissue development | GO:0061448 | 179 | 0.048 | |
| female sex differentiation | GO:0046660 | 84 | 0.048 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.048 | |
| respiratory tube development | GO:0030323 | 167 | 0.047 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.047 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.047 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.047 | |
| muscle fiber development | GO:0048747 | 76 | 0.047 | |
| axonogenesis | GO:0007409 | 274 | 0.047 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.047 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.046 | |
| dna metabolic process | GO:0006259 | 303 | 0.046 | Human |
| blood coagulation | GO:0007596 | 76 | 0.046 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.046 | |
| muscle contraction | GO:0006936 | 101 | 0.046 | |
| epidermis development | GO:0008544 | 187 | 0.046 | |
| tissue homeostasis | GO:0001894 | 115 | 0.046 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.045 | |
| ovarian follicle development | GO:0001541 | 40 | 0.045 | |
| angiogenesis | GO:0001525 | 201 | 0.045 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.044 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.044 | |
| skin development | GO:0043588 | 220 | 0.044 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.044 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.043 | |
| wound healing | GO:0042060 | 157 | 0.043 | |
| epithelial cell development | GO:0002064 | 159 | 0.043 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.043 | |
| striated muscle cell development | GO:0055002 | 125 | 0.043 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.042 | |
| muscle tissue development | GO:0060537 | 308 | 0.042 | |
| glomerulus development | GO:0032835 | 40 | 0.042 | |
| camera type eye development | GO:0043010 | 266 | 0.042 | |
| neuron death | GO:0070997 | 154 | 0.041 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.041 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.041 | |
| protein o linked glycosylation | GO:0006493 | 16 | 0.040 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.040 | |
| chemotaxis | GO:0006935 | 247 | 0.040 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.040 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.040 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.040 | |
| regulation of defense response | GO:0031347 | 233 | 0.040 | |
| coagulation | GO:0050817 | 78 | 0.040 | |
| neuropilin signaling pathway | GO:0038189 | 2 | 0.039 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.039 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.039 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.038 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.038 | |
| regulation of neuron death | GO:1901214 | 134 | 0.038 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.038 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.038 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.038 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.038 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.038 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.037 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.037 | |
| muscle cell development | GO:0055001 | 133 | 0.037 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.036 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.036 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.036 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.036 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.036 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.035 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.035 | |
| regulation of cell motility | GO:2000145 | 236 | 0.035 | |
| regulation of cell migration | GO:0030334 | 219 | 0.035 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.035 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.035 | |
| heart contraction | GO:0060047 | 93 | 0.034 | |
| heart morphogenesis | GO:0003007 | 178 | 0.034 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.034 | |
| hair cycle | GO:0042633 | 90 | 0.034 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.034 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.034 | |
| negative chemotaxis | GO:0050919 | 14 | 0.033 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.033 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.033 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.033 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.033 | |
| developmental maturation | GO:0021700 | 193 | 0.033 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.033 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.033 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.033 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.033 | |
| transmembrane transport | GO:0055085 | 412 | 0.033 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.032 | |
| skeletal system development | GO:0001501 | 356 | 0.032 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.032 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.032 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.032 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.032 | |
| striated muscle contraction | GO:0006941 | 45 | 0.032 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.032 | |
| nephron epithelium development | GO:0072009 | 92 | 0.032 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.032 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.032 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.032 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.031 | |
| stem cell proliferation | GO:0072089 | 117 | 0.031 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.031 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.031 | |
| gonad development | GO:0008406 | 141 | 0.031 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.031 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.031 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.031 | |
| ossification | GO:0001503 | 216 | 0.031 | |
| t cell activation | GO:0042110 | 289 | 0.031 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.031 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.031 | Human |
| mesangial cell differentiation | GO:0072007 | 4 | 0.030 | |
| anion transport | GO:0006820 | 177 | 0.030 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.030 | |
| cellular response to vascular endothelial growth factor stimulus | GO:0035924 | 11 | 0.030 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.030 | |
| mesonephros development | GO:0001823 | 97 | 0.030 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.030 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.030 | |
| activation of immune response | GO:0002253 | 138 | 0.030 | |
| embryonic placenta development | GO:0001892 | 98 | 0.030 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.030 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.030 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.030 | |
| regulation of protein transport | GO:0051223 | 163 | 0.030 | |
| nephron tubule development | GO:0072080 | 84 | 0.029 | |
| protein maturation | GO:0051604 | 176 | 0.029 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.029 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.029 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.029 | |
| regulation of cell size | GO:0008361 | 72 | 0.029 | |
| intracellular protein transport | GO:0006886 | 204 | 0.029 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.029 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.029 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.029 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.029 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.029 | |
| response to oxidative stress | GO:0006979 | 123 | 0.028 | |
| ureteric bud development | GO:0001657 | 94 | 0.028 | |
| body fluid secretion | GO:0007589 | 53 | 0.028 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.028 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.028 | |
| digestive system development | GO:0055123 | 200 | 0.028 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.028 | |
| paracrine signaling | GO:0038001 | 1 | 0.028 | |
| primitive erythrocyte differentiation | GO:0060319 | 3 | 0.028 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.028 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.028 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.028 | |
| extracellular structure organization | GO:0043062 | 148 | 0.028 | |
| cell maturation | GO:0048469 | 127 | 0.028 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.028 | |
| heart process | GO:0003015 | 94 | 0.028 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.028 | |
| inflammatory response | GO:0006954 | 244 | 0.028 | |
| cellular homeostasis | GO:0019725 | 240 | 0.027 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.027 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.027 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.027 | |
| metanephric glomerular endothelium development | GO:0072264 | 1 | 0.027 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.027 | |
| defense response to other organism | GO:0098542 | 197 | 0.027 | |
| organic acid transport | GO:0015849 | 101 | 0.027 | |
| neuron projection guidance | GO:0097485 | 141 | 0.027 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.027 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.027 | |
| renal tubule development | GO:0061326 | 87 | 0.027 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.027 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.027 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.027 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.026 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| lung vasculature development | GO:0060426 | 7 | 0.026 | |
| stem cell differentiation | GO:0048863 | 268 | 0.026 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.026 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.026 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.026 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.026 | |
| cellular response to x ray | GO:0071481 | 2 | 0.026 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.026 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.026 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.026 | Human |
| platelet activation | GO:0030168 | 40 | 0.026 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.026 | |
| hair follicle development | GO:0001942 | 85 | 0.026 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.025 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.025 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.025 | |
| molting cycle | GO:0042303 | 90 | 0.025 | |
| cellular response to radiation | GO:0071478 | 28 | 0.025 | |
| cellular response to lipid | GO:0071396 | 145 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.025 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.025 | |
| forebrain development | GO:0030900 | 302 | 0.025 | |
| sensory perception | GO:0007600 | 245 | 0.024 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.024 | |
| immune effector process | GO:0002252 | 321 | 0.024 | |
| protein processing | GO:0016485 | 163 | 0.024 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.024 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.024 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.024 | |
| mesangial cell development | GO:0072143 | 4 | 0.024 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.024 | |
| chemical homeostasis within a tissue | GO:0048875 | 9 | 0.024 | |
| phosphatidylinositol metabolic process | GO:0046488 | 45 | 0.024 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.024 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.023 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.023 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.023 | |
| positive regulation of retinal ganglion cell axon guidance | GO:1902336 | 2 | 0.023 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.023 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.023 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.023 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.023 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.023 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.023 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.023 | |
| regulation of cell growth | GO:0001558 | 91 | 0.023 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.023 | |
| ear development | GO:0043583 | 200 | 0.023 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.023 | |
| organic anion transport | GO:0015711 | 137 | 0.023 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.022 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.022 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.022 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.022 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.022 | |
| regulation of glomerular filtration | GO:0003093 | 3 | 0.022 | |
| compound eye development | GO:0048749 | 1 | 0.022 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.022 | |
| developmental cell growth | GO:0048588 | 84 | 0.022 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.022 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.022 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.022 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.022 | |
| regulation of protein localization | GO:0032880 | 231 | 0.022 | |
| mammary gland lobule development | GO:0061377 | 22 | 0.022 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.022 | |
| regulation of hematopoietic progenitor cell differentiation | GO:1901532 | 18 | 0.022 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.022 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.021 | |
| metanephros development | GO:0001656 | 79 | 0.021 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.021 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.021 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.021 | |
| axon guidance | GO:0007411 | 141 | 0.021 | |
| positive regulation of mitotic cell cycle embryonic | GO:0045977 | 2 | 0.021 | |
| cell growth | GO:0016049 | 130 | 0.021 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.021 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.021 | |
| limb development | GO:0060173 | 166 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.020 | |
| response to peptide | GO:1901652 | 136 | 0.020 | |
| respiratory system development | GO:0060541 | 190 | 0.020 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.020 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.020 | |
| regulation of ion transport | GO:0043269 | 215 | 0.020 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.020 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.020 | |
| biomineral tissue development | GO:0031214 | 64 | 0.020 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.020 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.020 | |
| locomotory behavior | GO:0007626 | 195 | 0.020 | |
| tube formation | GO:0035148 | 140 | 0.020 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.020 | |
| regulation of ossification | GO:0030278 | 112 | 0.020 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.020 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.020 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.020 | |
| cation transport | GO:0006812 | 399 | 0.020 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.020 | |
| endocytosis | GO:0006897 | 168 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| protein localization to organelle | GO:0033365 | 185 | 0.020 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.020 | |
| appendage development | GO:0048736 | 166 | 0.020 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.020 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.020 | |
| regulation of secretion | GO:0051046 | 274 | 0.020 | |
| positive regulation of growth | GO:0045927 | 104 | 0.020 | |
| protein secretion | GO:0009306 | 111 | 0.020 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.020 | |
| cell differentiation involved in metanephros development | GO:0072202 | 12 | 0.020 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.019 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.019 | |
| lactation | GO:0007595 | 25 | 0.019 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.019 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.019 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.019 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.019 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.019 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.019 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.019 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.019 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.019 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.019 | |
| membrane organization | GO:0061024 | 245 | 0.019 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.019 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.019 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.019 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.019 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.019 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| positive regulation of glomerular filtration | GO:0003104 | 1 | 0.018 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.018 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.018 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.018 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.018 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.018 | |
| response to acid chemical | GO:0001101 | 111 | 0.018 | |
| neuron projection extension | GO:1990138 | 64 | 0.018 | |
| regulation of kidney development | GO:0090183 | 40 | 0.018 | |
| kidney vasculature development | GO:0061440 | 15 | 0.018 | |
| ovulation cycle | GO:0042698 | 59 | 0.018 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.018 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.018 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.018 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.018 | |
| negative regulation of phospholipid biosynthetic process | GO:0071072 | 1 | 0.018 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.018 | |
| organelle localization | GO:0051640 | 179 | 0.018 | |
| nuclear transport | GO:0051169 | 139 | 0.018 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.017 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.017 | |
| maintenance of location | GO:0051235 | 89 | 0.017 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.017 | |
| regulation of axon extension | GO:0030516 | 43 | 0.017 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.017 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.017 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.017 | |
| platelet derived growth factor receptor beta signaling pathway | GO:0035791 | 4 | 0.017 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.017 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.017 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.017 | |
| cell proliferation involved in kidney development | GO:0072111 | 14 | 0.017 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.017 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.017 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.017 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.017 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.017 | |
| response to nutrient levels | GO:0031667 | 109 | 0.017 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.017 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.017 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.017 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.017 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.017 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.017 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.017 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.017 | |
| digestive tract development | GO:0048565 | 190 | 0.017 | |
| regulation of retinal ganglion cell axon guidance | GO:0090259 | 2 | 0.016 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.016 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.016 | |
| fat cell differentiation | GO:0045444 | 160 | 0.016 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.016 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.016 | |
| cartilage development | GO:0051216 | 140 | 0.016 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.016 | |
| regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling | GO:0060683 | 1 | 0.016 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.016 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.016 | |
| telencephalon development | GO:0021537 | 186 | 0.016 | |
| limb morphogenesis | GO:0035108 | 149 | 0.016 | |
| positive regulation of lymphangiogenesis | GO:1901492 | 3 | 0.016 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.016 | |
| cardiac cell development | GO:0055006 | 41 | 0.016 | |
| response to inorganic substance | GO:0010035 | 96 | 0.016 | |
| endothelial cell migration | GO:0043542 | 44 | 0.016 | |
| bone mineralization | GO:0030282 | 54 | 0.016 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.016 | Human |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.016 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.016 | |
| lipid localization | GO:0010876 | 126 | 0.016 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.016 | |
| metanephric mesangial cell differentiation | GO:0072209 | 1 | 0.016 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.016 | |
| regulation of coagulation | GO:0050818 | 31 | 0.015 | |
| phosphatidylinositol biosynthetic process | GO:0006661 | 15 | 0.015 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.015 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.015 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.015 | |
| endomembrane system organization | GO:0010256 | 147 | 0.015 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.015 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.015 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.015 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.015 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.015 | |
